Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.22 USD | -1.24% |
|
-4.18% | -19.87% |
06-25 | Orion Obtains License to Market Navamedic's Parkinson's Disease Drug in Europe | MT |
06-25 | Moody's Affirms Orion Ratings on Market Position, Operating Profitability | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.87% | 1.31B | |
+21.59% | 69.86B | |
-6.07% | 46.18B | |
+24.77% | 44.91B | |
+32.17% | 27.73B | |
+8.81% | 19.55B | |
+15.37% | 17.2B | |
-13.50% | 15.19B | |
-28.13% | 14.41B | |
-33.19% | 11.62B |
- Stock Market
- Equities
- OEC Stock
- News Orion S.A.
- Orion Minerals Shareholder to Exercise 25 Million Stock Options